Buy or sell Scorpion Therapeutics stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Scorpion Therapeutics Stock
Scorpion Therapeutics is a precision oncology company that broadens the reach and impact of precision medicine for cancer patients.
About Scorpion Therapeutics Stock
Scorpion Therapeutics was founded to broaden the reach and impact of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology.
Funding History
October 2020 | $108M |
---|---|
January 2021 | $162M |
Management
Founder
Gaddy Getz
Interim Chief Executive Officer
Adam Friedman
Co-Founder & Board Member
Keith Flaherty
Chief Financial Officer
Brian Piper
Founder
Liron Bar-Peled
Board Observer
Paulina Hill
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase